海外の治験の状況「前立腺癌」での検索結果
167件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- ODM-201 in Addition to Standard ADT and Docetaxel in Metastatic Castration Sensitive Prostate Cancer
- Prostatic Neoplasms
- Australia, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, Czechia, Finland, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
- 2016-06-06
Authorised
- An Investigational Immunotherapy Study to Determine Which Combination of Nivolumab plus Several Other Drugs, is the Most Effective in Treating Castration-resistant Prostate Cancer That Has Spread
- Castration-resistant Metastatic Prostate Cancer br>MedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: LLT Classification code 10076506 Term: Castration-resistant prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Brazil, Canada, Chile, Colombia, France, Germany, Mexico, Spain
- 2017-12-01
Authorised
- A study to provide access to continued treatment for subjects with prostate cancer who are currently participating in an enzalutamide clinical study
- metastatic castration-resistant prostate cancer br>MedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Belgium, Canada, Chile, Czech Republic, Denmark, Finland, France, Georgia, Germany, Israel, Italy, Japan, Korea, Republic of, Lithuania, Moldova, Republic of, Netherlands, New Zealand, Russian Federation, Slovakia, South Africa, Spain, Sweden, Taiwan, United Kingdom, United States
- 2016-09-30
Not recruiting
- Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Australia, Brazil, China, Korea, Republic of, Kuwait, Lebanon, New Zealand, Saudi Arabia, Taiwan, Thailand
- 2005-10-19
Recruiting
- A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer
- Prostate Cancer
- Australia, Austria, Belgium, Brazil, Canada, Denmark, Finland, France, Germany, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Slovakia, Spain, Sweden, Taiwan, United Kingdom, United States
- 2017-03-09
Not recruiting
- A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer
- Prostate Cancer;Castration-resistant Prostate Cancer;Metastatic Prostate Cancer
- Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, France, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, United Kingdom
- 2014-02-18
Not recruiting
- Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
- Hormone Sensitive Prostate Cancer;Prostate Cancer;Cancer of the Prostate
- Australia, Austria, Brazil, Canada, Denmark, Finland, France, Italy, Korea, Republic of, Netherlands, Poland, Slovakia, Spain, Sweden, Taiwan, United Kingdom, United States
- 2014-12-14
Not recruiting
- Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical Prostatectomy
- Prostate Cancer;Prostate Cancer;Prostate Cancer
- Brazil
- 2013-03-12
Not recruiting
- A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Argentina, Australia, Brazil, Canada, Czech Republic, Finland, France, Germany, Hungary, India, Italy, Korea, Republic of, Netherlands, Norway, Peru, Poland, Portugal, Romania, Russian Federation, Serbia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
- 2008-01-24
Not recruiting
- A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Finland, Former Serbia and Montenegro, France, Germany, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Republic of, Latvia, Mexico, Netherlands, Norway, Peru, Poland, Portugal, Romania, Russian Federation, Serbia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, United States
- 2008-01-24